Woodford Debacle Is A Test Of UK Biotech’s Resilience
Investor's Downfall Is Unwelcome Distraction
As once-star investment funds fail, another major investor argues this is opportunity for UK biotech to demonstrate staying power.

As once-star investment funds fail, another major investor argues this is opportunity for UK biotech to demonstrate staying power.